Close Window

Digital Look Email A Friend

Bioventix revenue rises in tougher first half

Published by Josh White on 29th March 2021

(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to 5.2m.


Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.